Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Global Market Report 2025

Description

Artificial intelligence (AI) in in vitro diagnostics (IVD) refers to the application of advanced algorithms to analyze medical data obtained from laboratory tests on samples such as blood, tissue, or urine. It enables faster, more accurate, and data-driven interpretation of test results, supporting early disease detection, personalized treatment decisions, and enhanced diagnostic efficiency.

The primary components of AI in in vitro diagnostics include software, hardware, and services. Software consists of programs and data that instruct a computer to perform specific tasks. It leverages technologies such as machine learning, natural language processing, computer vision, robotic process automation, and deep learning, and can be deployed through cloud-based, on-premise, or hybrid methods. Applications include diagnostic imaging, laboratory testing, pathology, genomics, and personalized medicine. Primary end users include hospitals and clinics, diagnostic laboratories, research institutes, pharmaceutical companies, and medical device manufacturers.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers' margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

The artificial intelligence (AI) in in vitro diagnostics market research report is one of a series of new reports from The Business Research Company that provides artificial intelligence (AI) in in vitro diagnostics market statistics, including artificial intelligence (AI) in the in vitro diagnostics industry's global market size, regional shares, competitors with an artificial intelligence (AI) in the in vitro diagnostics market share, detailed artificial intelligence (AI) in in vitro diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the artificial intelligence (AI) in the in vitro diagnostics industry. This artificial intelligence (AI) in vitro diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The artificial intelligence (AI) in in vitro diagnostics (IVD) market size has grown rapidly in recent years. It will grow from $2.57 billion in 2024 to $3.04 billion in 2025 at a compound annual growth rate (CAGR) of 18.5%. Growth in the historic period was driven by a shortage of skilled healthcare professionals and radiologists, increasing government and regulatory support for AI-based diagnostics, growing application of AI in genomic and molecular diagnostics, rising awareness among clinicians of AI-enabled diagnostic accuracy, and greater availability of cloud-based AI diagnostic solutions.

The artificial intelligence (AI) in in vitro diagnostics (IVD) market size is expected to see rapid growth in the next few years. It will grow to $5.94 billion in 2029 at a compound annual growth rate (CAGR) of 18.2%. Growth in the forecast period is expected to result from increasing demand for rapid and accurate diagnostic results, higher prevalence of chronic and infectious diseases, growing need for personalized and precision medicine approaches, stronger focus on early disease detection and prevention, and greater healthcare digitization with widespread adoption of electronic health records. Primary trends anticipated for the forecast period include advancements in deep learning for pathology and imaging, innovations in fully automated high-throughput analyzers, integration of natural language processing in diagnostic reporting, development of AI-enabled remote diagnostic platforms, and integration of AI with wearable and point-of-care devices.

The growing demand for personalized medicine is expected to drive the expansion of the artificial intelligence (AI) in in vitro diagnostics (IVD) market. Personalized medicine involves tailoring prevention, diagnosis, and treatment based on an individual's genetic profile, lifestyle, and environment. The increasing adoption of personalized medicine is largely fueled by advancements in genomic data and sequencing technologies, which allow for more precise, effective, and targeted treatments. AI in IVD plays a vital role by analyzing complex diagnostic data to identify disease patterns specific to each patient, helping healthcare providers make timely and accurate treatment decisions. For example, the Personalized Medicine Coalition reported that in February 2024, the FDA approved 16 new personalized treatments for rare diseases in 2023, a significant increase from six in 2022. This includes seven cancer drugs and three treatments for other conditions. The rising demand for personalized medicine is thus driving the growth of AI in IVD.

Companies in the AI in IVD market are focused on developing advanced solutions, such as CE-IVDR-certified transparent AI platforms, to improve diagnostic accuracy, streamline workflows, and support personalized patient care. A CE-IVDR-certified transparent AI platform is an AI system that meets EU regulatory standards, providing clear, auditable decision-making. In May 2025, Diagnostics.ai, a UK-based diagnostic testing company, launched PCR.AI, an advanced solution designed to speed up and improve PCR diagnostics. This platform automates real-time PCR result interpretation with over 99.9% accuracy, offering transparency by clearly displaying how each result is derived. This feature ensures regulatory compliance and enhances clinical trust. It also significantly boosts laboratory efficiency, reduces errors, and supports seamless regulatory adherence for molecular diagnostics.

In April 2025, bioMerieux SA, a France-based company specializing in AI for IVD, partnered with Mila, a Canadian AI research institute, to advance research and innovation in AI-driven diagnostics and antibiotic resistance detection. The collaboration aims to create cutting-edge AI solutions that enhance the accuracy and efficiency of IVD tools, with a particular focus on improving the detection of antibiotic resistance. Mila is renowned for its pioneering work in machine learning and AI research.

Major players in the artificial intelligence (AI) in in vitro diagnostics (IVD) market are Roche Diagnostics GmbH, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Illumina Inc., Hologic Inc., Sysmex Corporation, QIAGEN N.V., Tempus Labs Inc., BillionToOne Inc., PathAI Inc., Proscia Inc., Indica Labs Inc., Visiopharm A/S, aetherAI Co. Ltd., Ibex Medical Analytics Ltd., Mindpeak GmbH, OncoHost Ltd., Qritive, and Aiforia Technologies Oyj.

North America was the largest region in the artificial intelligence (AI) in in vitro diagnostics (IVD) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in artificial intelligence (AI) in in vitro diagnostics (IVD) report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the artificial intelligence (AI) in in vitro diagnostics (IVD) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The artificial intelligence (AI) in in vitro diagnostics (IVD) market includes revenues earned by entities by providing services such as predictive analytics services, remote diagnostic and telepathology services, workflow automation, optimization services, data annotation, and clinical decision support services. The market value includes the value of related goods sold by the service provider or included within the service offering. The artificial intelligence (AI) in in vitro diagnostics (IVD) market also includes sales of automated laboratory instruments, artificial intelligence-enabled digital pathology scanners, and liquid biopsy diagnostic kits. Values in this market are 'factory gate' values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on artificial intelligence (ai) in in vitro diagnostics (ivd) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for artificial intelligence (ai) in in vitro diagnostics (ivd) ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The artificial intelligence (ai) in in vitro diagnostics (ivd) market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Component: Software; Hardware; Services
2) By Technology: Machine Learning; Natural Language Processing; Computer Vision; Robotics Process Automation; Deep Learning
3) By Deployment Model: Cloud-Based; On-Premise; Hybrid
4) By Application: Diagnostic Imaging; Laboratory Testing; Pathology; Genomics; Personalized Medicine
5) By End User: Hospitals And Clinics; Diagnostic Laboratories; Research Institutes; Pharmaceutical Companies; Medical Device Manufacturers
Subsegments:
1) By Software: Diagnostic Algorithms; Data Analytics Platforms; Decision Support Systems
2) By Hardware: Laboratory Instruments; Imaging Devices; Point-Of-Care Devices
3) By Services: Consulting And Implementation; Maintenance And Support; Training And Education
Companies Mentioned: Roche Diagnostics GmbH; Thermo Fisher Scientific Inc.; Abbott Laboratories; Danaher Corporation; Siemens Healthineers AG; Illumina Inc.; Hologic Inc.; Sysmex Corporation; QIAGEN N.V.; Tempus Labs Inc.; BillionToOne Inc.; PathAI Inc.; Proscia Inc.; Indica Labs Inc.; Visiopharm A/S; aetherAI Co. Ltd.; Ibex Medical Analytics Ltd.; Mindpeak GmbH; OncoHost Ltd.; Qritive; Aiforia Technologies Oyj.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.

Product Code: r38426

1. Executive Summary

2. Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Characteristics

3. Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Trends And Strategies

4. Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Growth Analysis And Strategic Analysis Framework

5.1. Global Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Growth Rate Analysis
5.4. Global Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Total Addressable Market (TAM)

6. Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Segmentation

6.1. Global Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Software
Hardware
Services
6.2. Global Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Machine Learning
Natural Language Processing
Computer Vision
Robotics Process Automation
Deep Learning
6.3. Global Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Deployment Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Cloud-Based
On-Premise
Hybrid
6.4. Global Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Diagnostic Imaging
Laboratory Testing
Pathology
Genomics
Personalized Medicine
6.5. Global Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals And Clinics
Diagnostic Laboratories
Research Institutes
Pharmaceutical Companies
Medical Device Manufacturers
6.6. Global Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Diagnostic Algorithms
Data Analytics Platforms
Decision Support Systems
6.7. Global Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Sub-Segmentation Of Hardware, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Laboratory Instruments
Imaging Devices
Point-Of-Care Devices
6.8. Global Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Consulting And Implementation
Maintenance And Support
Training And Education

7. Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Regional And Country Analysis

7.1. Global Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market

8.1. Asia-Pacific Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Deployment Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market

9.1. China Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Overview
9.2. China Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Deployment Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market

10.1. India Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Deployment Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market

11.1. Japan Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Overview
11.2. Japan Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Deployment Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market

12.1. Australia Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Deployment Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market

13.1. Indonesia Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Deployment Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market

14.1. South Korea Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Overview
14.2. South Korea Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Deployment Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market

15.1. Western Europe Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Overview
15.2. Western Europe Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Deployment Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market

16.1. UK Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Deployment Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market

17.1. Germany Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Deployment Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market

18.1. France Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Deployment Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market

19.1. Italy Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Deployment Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market

20.1. Spain Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Deployment Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market

21.1. Eastern Europe Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Overview
21.2. Eastern Europe Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Deployment Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market

22.1. Russia Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Deployment Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market

23.1. North America Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Overview
23.2. North America Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Deployment Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market

24.1. USA Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Overview
24.2. USA Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Deployment Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market

25.1. Canada Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Overview
25.2. Canada Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Deployment Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market

26.1. South America Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Overview
26.2. South America Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Deployment Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market

27.1. Brazil Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Deployment Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market

28.1. Middle East Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Overview
28.2. Middle East Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Deployment Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market

29.1. Africa Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Overview
29.2. Africa Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Deployment Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Competitive Landscape And Company Profiles

30.1. Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Competitive Landscape
30.2. Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Company Profiles
- 30.2.1. Roche Diagnostics GmbH Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis

31. Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Other Major And Innovative Companies

31.1. Illumina Inc.
31.2. Hologic Inc.
31.3. Sysmex Corporation
31.4. QIAGEN N.V.
31.5. Tempus Labs Inc.
31.6. BillionToOne Inc.
31.7. PathAI Inc.
31.8. Proscia Inc.
31.9. Indica Labs Inc.
31.10. Visiopharm A/S
31.11. aetherAI Co. Ltd.
31.12. Ibex Medical Analytics Ltd.
31.13. Mindpeak GmbH
31.14. OncoHost Ltd.
31.15. Qritive

32. Global Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market

34. Recent Developments In The Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market

35. Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market High Potential Countries, Segments and Strategies

35.1 Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market In 2029 - Countries Offering Most New Opportunities
35.2 Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market In 2029 - Segments Offering Most New Opportunities
35.3 Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer